source
- CVS agrees to $315 million settlement over alleged improper opioid prescriptionsCVS Pharmacy has agreed to pay $315 million to settle federal allegations that it dispensed unnecessary opioid prescriptions. The Justice Department claims the company filled prescriptions that we…
- Arrowhead’s experimental RNAi drug ARO-MAPT cuts tau protein by 73% in early human trialArrowhead Pharmaceuticals said its experimental RNA interference therapy, ARO-MAPT, lowered the Alzheimer’s‑linked tau protein in a first‑in‑human study of healthy volunteers. The early‑stage tria…